FDA Panel Suggests Adding Pediatric Risk Warning To GSK’s Serevent Label
This article was originally published in The Pink Sheet Daily
Executive Summary
Pediatric Advisory Committee also suggests changes in Cephalon’s Provigil label that exclude use in pediatric population.